Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
Zhang, Jiawei2,3; Wu, Yinan3,4; Mu, Jiayi3; Xin, Dijia2; Wang, Luyao2; Fan, Yili2; Zhang, Suzhan3; Xu, Yang1,2
刊名FRONTIERS IN ONCOLOGY
2022-09-20
卷号12
关键词colorectal cancer glycosyltransferase lncRNAs risk model overall survival
ISSN号2234-943X
DOI10.3389/fonc.2022.954226
通讯作者Zhang, Suzhan(zuci@zju.edu.cn) ; Xu, Yang(yxu@zju.edu.cn)
英文摘要PurposeColon adenocarcinoma (COAD) is the most common type of colorectal cancer (CRC) and is associated with poor prognosis. Emerging evidence has demonstrated that glycosylation by long noncoding RNAs (lncRNAs) was associated with COAD progression. To date, however, the prognostic values of glycosyltransferase (GT)-related lncRNAs in COAD are still largely unknown. MethodsWe obtained the expression matrix of mRNAs and lncRNAs in COAD from The Cancer Genome Atlas (TCGA) database. Then, the univariate Cox regression analysis was conducted to identify 33 prognostic GT-related lncRNAs. Subsequently, LASSO and multivariate Cox regression analysis were performed, and 7 of 33 GT-related lncRNAs were selected to conduct a risk model. Gene set enrichment analysis (GSEA) was used to analyze gene signaling pathway enrichment of the risk model. ImmuCellAI, an online tool for estimating the abundance of immune cells, and correlation analysis were used to explore the tumor-infiltrating immune cells in COAD. Finally, the expression levels of seven lncRNAs were detected in colorectal cancer cell lines by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). ResultsA total of 1,140 GT-related lncRNAs were identified, and 7 COAD-specific GT-related lncRNAs (LINC02381, MIR210HG, AC009237.14, AC105219.1, ZEB1-AS1, AC002310.1, and AC020558.2) were selected to conduct a risk model. Patients were divided into high- and low-risk groups based on the median of risk score. The prognosis of the high-risk group was worse than that of the low-risk group, indicating the good reliability and specificity of our risk model. Additionally, a nomogram based on the risk score and clinical traits was built to help clinical decisions. GSEA showed that the risk model was significantly enriched in metabolism-related pathways. Immune infiltration analysis revealed that five types of immune cells were significantly different between groups, and two types of immune cells were negatively correlated with the risk score. Besides, we found that the expression levels of these seven lncRNAs in tumor cells were significantly higher than those in normal cells, which verified the feasibility of the risk model. ConclusionThe efficient risk model based on seven GT-related lncRNAs has prognostic potential for COAD, which may be novel biomarkers and therapeutic targets for COAD patients.
资助项目Natural Science Foundation of Zhejiang Province of China ; National Natural Science Foundation of China ; [LY21H080005] ; [81572920]
WOS关键词PROGRESSION ; CURVES
WOS研究方向Oncology
语种英语
出版者FRONTIERS MEDIA SA
WOS记录号WOS:000863686300001
资助机构Natural Science Foundation of Zhejiang Province of China ; National Natural Science Foundation of China
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129207]  
专题中国科学院合肥物质科学研究院
通讯作者Zhang, Suzhan; Xu, Yang
作者单位1.Zhejiang Univ, Life Sci Inst, Zhejiang Prov Key Lab Canc Mol Cell Biol, Hangzhou, Peoples R China
2.Zhejiang Univ, Affiliated Hosp 2, Dept Hematol, Sch Med, Hangzhou, Peoples R China
3.Zhejiang Univ, Zhejiang Univ Canc Inst, Affiliated Hosp 2, Key Lab Canc Prevent & Intervent,Sch Med,China Nat, Hangzhou, Peoples R China
4.Chinese Acad Sci, Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc,Canc Hosp, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Jiawei,Wu, Yinan,Mu, Jiayi,et al. Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma[J]. FRONTIERS IN ONCOLOGY,2022,12.
APA Zhang, Jiawei.,Wu, Yinan.,Mu, Jiayi.,Xin, Dijia.,Wang, Luyao.,...&Xu, Yang.(2022).Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma.FRONTIERS IN ONCOLOGY,12.
MLA Zhang, Jiawei,et al."Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma".FRONTIERS IN ONCOLOGY 12(2022).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace